InvestorsHub Logo
Followers 0
Posts 78
Boards Moderated 0
Alias Born 09/26/2018

Re: JustGoDeep post# 186709

Tuesday, 07/02/2019 8:01:17 AM

Tuesday, July 02, 2019 8:01:17 AM

Post# of 329415
B. Braun is supposed to be using SIX Actipatches per knee replacement. Whealan told us sales would show up 1st qtr. 2019, they did, $140K TOTAL SALES WORLDWIDE FOR THE COMPANY. This is down 75% from when they received FDA clearance for the knee and the foot. They cannot ship product because of the lack of a CE mark. It is difficult to believe B Braun is chomping at the bit to market in the US after Whealan failed to deliver product in the UK. However, if they are the chosen partner, the announcement could come any day. Does anyone wish to wager that they do not announce a partner in the next 60 days????

We will be sitting right where we are a year from now. Just as we are two plus years after receiving approval for the knee and foot, no sales in TWO YEARS!! He has no plan, he will start talking about a partnership with a large global company., "they have the money to market the product, Large companies move slowly........". He has said all of this before. If they do not know him by reputation, it will not take them as long as it took Bayer, KT Tape and others to run away.

THIS IS WHY THE STOCK DISAPPOINTED YESTERDAY. WHEALAN HAS BEEN EXPOSED.